ALISO VIEJO, Calif., Dec. 05, 2017 -- Cianna Medical, Inc., the world leader in wire-free breast localization, today announced the launch of SCOUTCare™, a comprehensive training, certification and communications program designed to support facilities in their adoption of the SAVI SCOUT® Radar Breast Localization system for wire-free breast tumor localization. The company introduced the program at the 2017 San Antonio Breast Cancer Symposium taking place from December 5-9, 2017, in San Antonio, Texas.
The SCOUTCare program is designed to support a facility’s mission of “moving beyond wires” through the adoption of the SCOUT® system to help reduce operating room costs, improve operational efficiency and reduce stress for women who are going through one of the most difficult times in their life. SCOUTCare provides multi-modality training for radiologists, surgeons and allied health professionals, including customized implementation planning, certification of clinical team and facility, coding and reimbursement guidance as well as a patient assistance program. The program also shares best practices from hospitals across the country that have successfully implanted their wire-free program.
“We are committed to assisting healthcare professionals in implementing a wire-free localization program. SCOUTCare, along with the SCOUT system, is just another way we’re helping to ease the burden of breast cancer for women and their families,” said Jill Anderson, President and CEO of Cianna Medical. “With SCOUTCare, we are able to align breast care programs across the U.S that are integrating their compassion for patients with our SCOUT technology. This program is one more way that we are helping our customers make breast cancer surgery easier for their patients.”
The SCOUT system is the first and only non-radioactive implant used in wire-free localization that can be implanted with no restrictions on the length of time the reflector can remain in the breast. Cianna Medical will also exhibit the SCOUT Radar Localization system during the course of the symposium at booth number 607.
SCOUT is designed for use by surgeons and radiologists to precisely locate and guide the removal of a tumor during a lumpectomy or surgical biopsy procedure. Using SCOUT, surgeons can precisely target the affected tissue using its 360˚ detection capability to pinpoint its location within ±1mm, which can mean more successful surgeries, optimized breast conservation strategies and enhanced outcomes for women. In addition, because the SCOUT reflector will not interfere with MRI studies, patients are not restricted in the types of imaging modalities they may need.
About SCOUT®
The SCOUT Breast Tumor Localization System features the first and only FDA-cleared implant used in wire-free localization that can be implanted long term, providing physicians with maximum flexibility to place the reflector for localization at any time during the continuum of care. The reflector will not interfere with MRI studies, which is critical when implants are placed long term. During the lumpectomy or surgical biopsy, the surgeon scans the breast using the SCOUT guide, which emits 50 million pulses per second, to “lock” on to the reflector’s position. The SCOUT Real-time Distance System is the only wire-free technology to offer 60mm detection range and 360° detection with ±1mm accuracy. This more advanced level of localization precision allows better surgical planning that may improve cosmetic results, as less tissue may need to be removed.
SCOUT has received significant recognition from medical societies and industry associations including, most recently, being honored as a Gold winner at the 2017 Medical Design Excellence Awards.
About Radar Technology
The SCOUT system uses highly sophisticated radar technology. Radar is used when unprecedented precision is required. Applications using radar include ground penetrating radar, automobile safety systems, flight control systems and antimissile and air-defense systems.
About Cianna Medical, Inc.
Cianna Medical is the world leader in wire-free breast localization and has been focused on breast conservation for over 10 years. Cianna Medical develops, manufactures and markets innovative medical technologies that reduce costs, improve quality and reduce the anxiety and stress breast cancer treatments place on women and their families. Cianna Medical’s world-class research, development and commercialization teams developed the world’s first non-radioactive, wire-free breast localization system and the world’s only technology that utilizes radar in tissue. Cianna Medical is focused on expanding applications that continually advance patient care. Its SCOUT and SAVI® Brachy technologies are FDA-cleared and address unmet needs in the delivery of radiation therapy, tumor localization and surgical guidance. Please visit www.ciannamedical.com for more information.
Media Contact:
Erich Sandoval
LAZAR PARTNERS for Cianna Medical
[email protected]
(917) 497-2867


SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Instagram Outage Disrupts Thousands of U.S. Users
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 



